Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG effects on nerve excitability in multifocal motor neuropathy
NL-OMON42955Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Nov 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of immune globulin in multifocal motor neuropathy (MMN), sponsored by University Medical Center Utrecht. Primary endpoint: Change in nerve excitability parameters after IVIG infusion. Started Nov 2016; status: active, not recruiting.
02
Drugs
immune globulin
03
Conditions
multifocal motor neuropathy (MMN)
Beyond the preview
Go deeper on NL-OMON42955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42955.